BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3540958)

  • 1. Acute insulin action requires insulin receptor kinase activity: introduction of an inhibitory monoclonal antibody into mammalian cells blocks the rapid effects of insulin.
    Morgan DO; Roth RA
    Proc Natl Acad Sci U S A; 1987 Jan; 84(1):41-5. PubMed ID: 3540958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies mimic insulin activation of ribosomal protein S6 kinase without activation of insulin receptor tyrosine kinase. Studies in cells transfected with normal and mutant human insulin receptors.
    Sung CK; Maddux BA; Hawley DM; Goldfine ID
    J Biol Chem; 1989 Nov; 264(32):18951-9. PubMed ID: 2553727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to the human insulin receptor that activate glucose transport but not insulin receptor kinase activity.
    Forsayeth JR; Caro JF; Sinha MK; Maddux BA; Goldfine ID
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3448-51. PubMed ID: 3033648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vanadyl sulfate-stimulated glycogen synthesis is associated with activation of phosphatidylinositol 3-kinase and is independent of insulin receptor tyrosine phosphorylation.
    Pandey SK; Anand-Srivastava MB; Srivastava AK
    Biochemistry; 1998 May; 37(19):7006-14. PubMed ID: 9578588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of insulin receptor kinase domain autophosphorylation in receptor-mediated activities. Analysis with insulin and anti-receptor antibodies.
    Wilden PA; Siddle K; Haring E; Backer JM; White MF; Kahn CR
    J Biol Chem; 1992 Jul; 267(19):13719-27. PubMed ID: 1320027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody to the human insulin receptor, but not insulin, stimulates S6 kinase via human insulin receptors mutated at three major tyrosine autophosphorylation sites.
    Sung CK
    J Cell Biochem; 1992 Mar; 48(3):324-35. PubMed ID: 1328257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of phosphotyrosyl-IRS-1 level and insulin receptor tyrosine kinase activity on insulin-stimulated phosphatidylinositol 3, MAP, and S6 kinase activities.
    Wilden PA; Broadway DE
    J Cell Physiol; 1995 Apr; 163(1):9-18. PubMed ID: 7896903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in the insulin receptor protein level by anti-insulin receptor antibodies: roles of tyrosine kinase activity and receptor internalization.
    Fujita N; Yamasaki H; Yamakawa K; Uotani S; Kuwahara H; Degawa-Yamauchi M; Abe T; Ozaki M; Sera Y; Kawasaki E; Takino H; Yamaguchi Y; Eguchi K
    Acta Diabetol; 2002 Dec; 39(4):221-7. PubMed ID: 12486497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin.
    Chou CK; Dull TJ; Russell DS; Gherzi R; Lebwohl D; Ullrich A; Rosen OM
    J Biol Chem; 1987 Feb; 262(4):1842-7. PubMed ID: 3100537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine phosphorylation of the receptor for insulin-like growth factor II is inhibited in plasma membranes from insulin-treated rat adipocytes.
    Corvera S; Yagaloff KA; Whitehead RE; Czech MP
    Biochem J; 1988 Feb; 250(1):47-52. PubMed ID: 2965577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of insulin signal transduction pathway by a small-molecule insulin receptor activator.
    Ding VD; Qureshi SA; Szalkowski D; Li Z; Biazzo-Ashnault DE; Xie D; Liu K; Jones AB; Moller DE; Zhang BB
    Biochem J; 2002 Oct; 367(Pt 1):301-6. PubMed ID: 12036431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of a selective insulin receptor tyrosine kinase inhibitor and its effect on glucose uptake and metabolism in intact cells.
    Saperstein R; Vicario PP; Strout HV; Brady E; Slater EE; Greenlee WJ; Ondeyka DL; Patchett AA; Hangauer DG
    Biochemistry; 1989 Jun; 28(13):5694-701. PubMed ID: 2550060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin receptor monoclonal antibodies that mimic insulin action without activating tyrosine kinase.
    Hawley DM; Maddux BA; Patel RG; Wong KY; Mamula PW; Firestone GL; Brunetti A; Verspohl E; Goldfine ID
    J Biol Chem; 1989 Feb; 264(5):2438-44. PubMed ID: 2536710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional trans-inactivation of insulin receptor kinase by growth-inhibitory angiotensin II AT2 receptor.
    Elbaz N; Bedecs K; Masson M; Sutren M; Strosberg AD; Nahmias C
    Mol Endocrinol; 2000 Jun; 14(6):795-804. PubMed ID: 10847582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to the insulin receptor (B-10) can stimulate tyrosine phosphorylation of the beta-subunit of the insulin receptor and a 185,000 molecular weight protein in rat hepatoma cells.
    Takayama-Hasumi S; Tobe K; Momomura K; Koshio O; Tashiro-Hashimoto Y; Akanuma Y; Hirata Y; Takaku F; Kasuga M
    J Clin Endocrinol Metab; 1989 Apr; 68(4):787-95. PubMed ID: 2466044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between insulin binding, insulin activation of insulin-receptor tyrosine kinase, and insulin stimulation of glucose uptake in isolated rat adipocytes. Effects of isoprenaline.
    Klein HH; Matthaei S; Drenkhan M; Ries W; Scriba PC
    Biochem J; 1991 Mar; 274 ( Pt 3)(Pt 3):787-92. PubMed ID: 2012605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and characterization of a functional human insulin-like growth factor I receptor.
    Steele-Perkins G; Turner J; Edman JC; Hari J; Pierce SB; Stover C; Rutter WJ; Roth RA
    J Biol Chem; 1988 Aug; 263(23):11486-92. PubMed ID: 2969892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The level of insulin receptor tyrosine kinase activity modulates the activities of phosphatidylinositol 3-kinase, microtubule-associated protein, and S6 kinases.
    Wilden PA; Kahn CR
    Mol Endocrinol; 1994 May; 8(5):558-67. PubMed ID: 8058065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose.
    Ellis L; Clauser E; Morgan DO; Edery M; Roth RA; Rutter WJ
    Cell; 1986 Jun; 45(5):721-32. PubMed ID: 3518947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wortmannin inhibits the effects of insulin and serum on the activities of glycogen synthase kinase-3 and mitogen-activated protein kinase.
    Welsh GI; Foulstone EJ; Young SW; Tavaré JM; Proud CG
    Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):15-20. PubMed ID: 7945234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.